Ginsenoside Rg1 interferes with the progression of diabetic osteoporosis by promoting type H angiogenesis modulating vasculogenic and osteogenic coupling

Ginsenoside Rg1 (Rg1) has been demonstrated to have antidiabetic and antiosteoporotic activities. The aim of this study was to investigate the protective effect of Rg1 against diabetic osteoporosis and the underlying mechanism. In vitro, we found that Rg1 increased the number of osteoprogenitors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenhui, Jin, Xinyan, Wang, Ting, Bai, Rui, Shi, Jun, Jiang, Yunxia, Tan, Simin, Wu, Ruijie, Zeng, Shiqi, Zheng, Hongxiang, Jia, Hongyang, Li, Shuanglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712449/
https://www.ncbi.nlm.nih.gov/pubmed/36467080
http://dx.doi.org/10.3389/fphar.2022.1010937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712449/
https://www.ncbi.nlm.nih.gov/pubmed/36467080
http://dx.doi.org/10.3389/fphar.2022.1010937

Ejemplares similares